Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol in Preoperative Gastrointestinal Cancer
NCT03245554Phase 1Unknown
- Sponsor
- Central South University
- Start
- May 2018
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in gastric adenocarcinoma and colon cancer comparing Propranolol with Placebo (2 arms). Primary endpoint: Tumor size at 1 week. Status: unknown.
02
Drugs
propranolol
03
Conditions
gastric adenocarcinomacolon cancer
Beyond the preview
Go deeper on NCT03245554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03245554.